New Concepts for Treatment of Non-Insulin-Dependent Diabetes Mellitus

Non-insulin-dependent diabetes mellitus remains a major cause of morbidity and premature mortality in our community. Although potentially amenable to control by lifestyle modification, this is difficult to achieve in practice. Additional approaches using drugs that enhance insulin secretion, suppres...

Full description

Saved in:
Bibliographic Details
Published in:Trends in endocrinology and metabolism 1997-07, Vol.8 (5), p.187-191
Main Author: Larkins, Richard G
Format: Article
Language:English
Subjects:
Biological and medical sciences
Hormones. Endocrine system
Medical sciences
Pharmacology. Drug treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c391t-4ac6b9b115cac99d8682624a89b1bc36031cf8cd4dd344829fb9e18c93af0b203
cites cdi_FETCH-LOGICAL-c391t-4ac6b9b115cac99d8682624a89b1bc36031cf8cd4dd344829fb9e18c93af0b203
container_end_page 191
container_issue 5
container_start_page 187
container_title Trends in endocrinology and metabolism
container_volume 8
creator Larkins, Richard G
description Non-insulin-dependent diabetes mellitus remains a major cause of morbidity and premature mortality in our community. Although potentially amenable to control by lifestyle modification, this is difficult to achieve in practice. Additional approaches using drugs that enhance insulin secretion, suppress hepatic glucose production, and increase insulin sensitivity are available, and new agents are being developed. The thiazolidinedione drugs hold particular promise as insulin-sensitizing agents; however, at present, insulin administration is often also required. The importance of detection and treatment of risk factors for cardiovascular disease and the earlier detection and management of microvascular and infective complications remain of crucial importance. (Trends Endocrinol Metab 1997;8:187–191). © 1997, Elsevier Science Inc.
doi_str_mv 10.1016/S1043-2760(97)00037-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734283294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043276097000374</els_id><sourcerecordid>734283294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-4ac6b9b115cac99d8682624a89b1bc36031cf8cd4dd344829fb9e18c93af0b203</originalsourceid><addsrcrecordid>eNqFkDtPwzAQgC0EoqXwE0AZkIAhYMeOY08ItQUqlTJQZstxLpJRHsVOQPx7kjbAyHSnu-8e-hA6JfiaYMJvXghmNIwSji9lcoUxpknI9tCYiESGFHOy3-U_yAgdef-GMWGCxIdoRATDXOB4jOYr-AymdWVg0_ggr12wdqCbEqomqPNgVVfhovJtYatwBhuosr4xszqFBnzwBEVhm9Yfo4NcFx5OhjhBr_fz9fQxXD4_LKZ3y9BQSZqQacNTmRISG22kzAQXEY-YFl0tNZRjSkwuTMayjDImIpmnEogwkuocpxGmE3Sx27tx9XsLvlGl9aZ7QldQt14llEWCRpJ1ZLwjjau9d5CrjbOldl-KYNULVFuBqrejZKK2AlU_dzZcaNMSsr-pwVgHnA-A9kYXudOVsf6XixIpOaEddrvDoNPxYcEpbyx0mjPrwDQqq-0_n3wDcQOLvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734283294</pqid></control><display><type>article</type><title>New Concepts for Treatment of Non-Insulin-Dependent Diabetes Mellitus</title><source>ScienceDirect Journals</source><creator>Larkins, Richard G</creator><creatorcontrib>Larkins, Richard G</creatorcontrib><description>Non-insulin-dependent diabetes mellitus remains a major cause of morbidity and premature mortality in our community. Although potentially amenable to control by lifestyle modification, this is difficult to achieve in practice. Additional approaches using drugs that enhance insulin secretion, suppress hepatic glucose production, and increase insulin sensitivity are available, and new agents are being developed. The thiazolidinedione drugs hold particular promise as insulin-sensitizing agents; however, at present, insulin administration is often also required. The importance of detection and treatment of risk factors for cardiovascular disease and the earlier detection and management of microvascular and infective complications remain of crucial importance. (Trends Endocrinol Metab 1997;8:187–191). © 1997, Elsevier Science Inc.</description><identifier>ISSN: 1043-2760</identifier><identifier>EISSN: 1879-3061</identifier><identifier>DOI: 10.1016/S1043-2760(97)00037-4</identifier><identifier>PMID: 18406805</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Hormones. Endocrine system ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Trends in endocrinology and metabolism, 1997-07, Vol.8 (5), p.187-191</ispartof><rights>1997 Elsevier Science Inc.</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-4ac6b9b115cac99d8682624a89b1bc36031cf8cd4dd344829fb9e18c93af0b203</citedby><cites>FETCH-LOGICAL-c391t-4ac6b9b115cac99d8682624a89b1bc36031cf8cd4dd344829fb9e18c93af0b203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2799613$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18406805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Larkins, Richard G</creatorcontrib><title>New Concepts for Treatment of Non-Insulin-Dependent Diabetes Mellitus</title><title>Trends in endocrinology and metabolism</title><addtitle>Trends Endocrinol Metab</addtitle><description>Non-insulin-dependent diabetes mellitus remains a major cause of morbidity and premature mortality in our community. Although potentially amenable to control by lifestyle modification, this is difficult to achieve in practice. Additional approaches using drugs that enhance insulin secretion, suppress hepatic glucose production, and increase insulin sensitivity are available, and new agents are being developed. The thiazolidinedione drugs hold particular promise as insulin-sensitizing agents; however, at present, insulin administration is often also required. The importance of detection and treatment of risk factors for cardiovascular disease and the earlier detection and management of microvascular and infective complications remain of crucial importance. (Trends Endocrinol Metab 1997;8:187–191). © 1997, Elsevier Science Inc.</description><subject>Biological and medical sciences</subject><subject>Hormones. Endocrine system</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>1043-2760</issn><issn>1879-3061</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkDtPwzAQgC0EoqXwE0AZkIAhYMeOY08ItQUqlTJQZstxLpJRHsVOQPx7kjbAyHSnu-8e-hA6JfiaYMJvXghmNIwSji9lcoUxpknI9tCYiESGFHOy3-U_yAgdef-GMWGCxIdoRATDXOB4jOYr-AymdWVg0_ggr12wdqCbEqomqPNgVVfhovJtYatwBhuosr4xszqFBnzwBEVhm9Yfo4NcFx5OhjhBr_fz9fQxXD4_LKZ3y9BQSZqQacNTmRISG22kzAQXEY-YFl0tNZRjSkwuTMayjDImIpmnEogwkuocpxGmE3Sx27tx9XsLvlGl9aZ7QldQt14llEWCRpJ1ZLwjjau9d5CrjbOldl-KYNULVFuBqrejZKK2AlU_dzZcaNMSsr-pwVgHnA-A9kYXudOVsf6XixIpOaEddrvDoNPxYcEpbyx0mjPrwDQqq-0_n3wDcQOLvg</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>Larkins, Richard G</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>New Concepts for Treatment of Non-Insulin-Dependent Diabetes Mellitus</title><author>Larkins, Richard G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-4ac6b9b115cac99d8682624a89b1bc36031cf8cd4dd344829fb9e18c93af0b203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>Hormones. Endocrine system</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Larkins, Richard G</creatorcontrib><collection>Pascal-Francis</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Larkins, Richard G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New Concepts for Treatment of Non-Insulin-Dependent Diabetes Mellitus</atitle><jtitle>Trends in endocrinology and metabolism</jtitle><addtitle>Trends Endocrinol Metab</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>8</volume><issue>5</issue><spage>187</spage><epage>191</epage><pages>187-191</pages><issn>1043-2760</issn><eissn>1879-3061</eissn><abstract>Non-insulin-dependent diabetes mellitus remains a major cause of morbidity and premature mortality in our community. Although potentially amenable to control by lifestyle modification, this is difficult to achieve in practice. Additional approaches using drugs that enhance insulin secretion, suppress hepatic glucose production, and increase insulin sensitivity are available, and new agents are being developed. The thiazolidinedione drugs hold particular promise as insulin-sensitizing agents; however, at present, insulin administration is often also required. The importance of detection and treatment of risk factors for cardiovascular disease and the earlier detection and management of microvascular and infective complications remain of crucial importance. (Trends Endocrinol Metab 1997;8:187–191). © 1997, Elsevier Science Inc.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>18406805</pmid><doi>10.1016/S1043-2760(97)00037-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-2760
ispartof Trends in endocrinology and metabolism, 1997-07, Vol.8 (5), p.187-191
issn 1043-2760
1879-3061
language eng
recordid cdi_proquest_miscellaneous_734283294
source ScienceDirect Journals
subjects Biological and medical sciences
Hormones. Endocrine system
Medical sciences
Pharmacology. Drug treatments
title New Concepts for Treatment of Non-Insulin-Dependent Diabetes Mellitus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A39%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20Concepts%20for%20Treatment%20of%20Non-Insulin-Dependent%20Diabetes%20Mellitus&rft.jtitle=Trends%20in%20endocrinology%20and%20metabolism&rft.au=Larkins,%20Richard%20G&rft.date=1997-07-01&rft.volume=8&rft.issue=5&rft.spage=187&rft.epage=191&rft.pages=187-191&rft.issn=1043-2760&rft.eissn=1879-3061&rft_id=info:doi/10.1016/S1043-2760(97)00037-4&rft_dat=%3Cproquest_cross%3E734283294%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c391t-4ac6b9b115cac99d8682624a89b1bc36031cf8cd4dd344829fb9e18c93af0b203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734283294&rft_id=info:pmid/18406805&rfr_iscdi=true